Tokyo, Japan · Founded 2020 · Privately Held (backing)
Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. Sonire Therapeutics is based in Tokyo, Japan and was founded in 2020. Its last reported valuation was $31.7 million in Nov 2022. It has raised $39.9 million across 1 recorded round; the latest was a $13.5 million early-stage round in Mar 2026.
Last reported valuation
$31.7M
Oct 2026
Priced at
—
Total raised
$39.9M
Last round
Early Stage VC
Mar 2026
Cap table — not yet on record
Sonire Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sonire Therapeutics with a free account
·The complete investor list: 27 names
·Watch Sonire Therapeutics: the Monday email on marks, rounds and moves
Where does Sonire Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Sonire Therapeutics's 1 recorded funding rounds.
